Feline Triaditis: Concurrent Disease Welfare Management

Key Welfare Considerations

• Triaditis reflects the anatomical proximity of the feline biliary, pancreatic, and intestinal systems.
• Simultaneous inflammation of all three systems creates synergistic welfare impairment beyond any single disease.
• Clinical signs include vomiting, lethargy, anorexia, and weight loss — acute welfare deterioration is common.
• Jaundice, when present, indicates cholangitis component causing hepatic welfare compromise.
• Ultrasonography reveals concurrent changes in multiple abdominal organs — essential welfare diagnostic tool.
• Biopsy confirmation of inflammatory changes in multiple systems guides welfare-appropriate treatment selection.
• Cholangitis component may be neutrophilic (bacterial) or lymphocytic (immune-mediated) — differentiation guides welfare treatment.
• Antibiotics are indicated for neutrophilic cholangitis — without treatment, hepatic welfare deterioration progresses.
• Prednisolone is the cornerstone of immune-mediated cholangitis and IBD welfare treatment.
• Pancreatitis management requires supportive care — fluids, anti-emetics, and nutritional support.
• Cobalamin (vitamin B12) deficiency commonly complicates IBD and triaditis — supplementation improves welfare.
• Ursodeoxycholic acid supports biliary welfare function and reduces cholestasis-associated liver injury.
• Appetite stimulants including mirtazapine support welfare nutrition during acute and chronic disease phases.
• Long-term management requires integration of all three conditions — single-organ focus causes welfare relapse.
• Regular monitoring of liver enzymes, pancreatic lipase, and body condition maintains welfare stability in triaditis.